Ru360
| Names | |
|---|---|
| IUPAC name
azanide;formic acid;ruthenium(5+);trichloride;hydrate
| |
| Other names
Ru360; (mu)[(HCO2)(NH3)4Ru]2OCl3
| |
| Identifiers | |
3D model (JSmol)
|
|
PubChem CID
|
|
| |
| |
| Properties | |
| C2H22Cl3N8O5Ru2- | |
| Molar mass | 546.74568 |
| Appearance | Reddish brown solid |
| deoxygenated H₂O | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
| |
Ru360 is an oxo-bridged dinuclear ruthenium ammine complex with an absorption spectrum maximum at 360 nm. It is an analog of ruthenium red, a well-known effective inhibitor of the mitochondrial calcium uniporter.[1]
Ru360 was discovered after scientists found that commercial preparations of ruthenium red were often less than 20% pure, and that the crude mixture produced a stronger inhibition than the purified product.[2] This component was later isolated and identified as Ru360.[1]
Since Ru360 inhibits the flow of calcium into mitochondria, which can prevent the opening of the mitochondrial permeability transition pore, it has been investigated as a therapeutic treatment for stroke and heart attack.[3]
References
- ^ a b Ying, W. L.; Emerson, J.; Clarke, M. J.; Sanadi, D. R. (1991-05-21). "Inhibition of mitochondrial calcium ion transport by an oxo-bridged dinuclear ruthenium ammine complex". Biochemistry. 30 (20): 4949–4952. doi:10.1021/bi00234a016. ISSN 0006-2960. PMID 2036363.
- ^ Broekemeier, K. M.; Krebsbach, R. J.; Pfeiffer, D. R. (1994-10-12). "Inhibition of the mitochondrial Ca2+ uniporter by pure and impure ruthenium red". Molecular and Cellular Biochemistry. 139 (1): 33–40. doi:10.1007/bf00944201. ISSN 0300-8177. PMID 7531818.
- ^ García-Rivas, G. de J.; Carvajal, K.; Correa, F.; Zazueta, C. (2006-12-01). "Ru360, a specific mitochondrial calcium uptake inhibitor, improves cardiac post-ischaemic functional recovery in rats in vivo". British Journal of Pharmacology. 149 (7): 829–837. doi:10.1038/sj.bjp.0706932. ISSN 0007-1188. PMC 2014682. PMID 17031386.